American Journal of Ophthalmology
Volume 149, Issue 1 , Pages 1-3 , January 2010

Are You Compliant With Addressing Glaucoma Adherence?

  • Steven L. Mansberger

      Affiliations

    • Corresponding Author InformationInquiries to Steven L. Mansberger, Devers Eye Institute, 1040 NW 22nd Ave, Suite 200, Portland, OR 97210

,Accepted 11 August 2009.

References 

  1. Friedman DS, Nordstrom B, Mozaffari E, Quigley HA. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology. 2005;112:1500–1504
  2. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–713discussion 829–830
  3. Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology. 1999;106:2144–2153
  4. Okeke CO, Quigley HA, Jampel HD, et al. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid Study. Ophthalmology. 2009;116:191–199
  5. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140:598–606
  6. Rogers PG, Bullman WR. Prescription medicine compliance: A review of the baseline of knowledge (A report of the National Council on Patient Information and Education). J Pharmacoepidemiology. 1996;3:3–36
  7. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124:1754–1760
  8. Herman DC, Gordon MO, Beiser JA, et al. Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study. Am J Ophthalmol. 2006;142:800–810
  9. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?. Am J Ophthalmol. 1986;101:524–530
  10. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101:515–523
  11. Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48:5052–5057
  12. Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144:533–540
  13. Friedman DS, Hahn SR, Gelb L, et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology. 2008;115:1320–1327
  14. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868–2879

PII: S0002-9394(09)00573-X

doi: 10.1016/j.ajo.2009.08.011

American Journal of Ophthalmology
Volume 149, Issue 1 , Pages 1-3 , January 2010

Article Tools